Pharma giant refused costs in HSE tender case

Pharma giant refused costs in HSE tender case

Because of its interest in the outcome, the pharmaceutical giant was joined as a notice party to a Commercial Court action brought by Sanofi against the HSE’s awarding of a tender for the six-in-one vaccine last January

Glaxosmithkline has been refused most of its costs following a legal row in which it said the “safety and efficacy” of one of its vaccines was being challenged by a global rival.

Because of its interest in the outcome, the pharmaceutical giant was joined as a notice party to a Commercial Court action brought by Sanofi against the HSE’s awarding of a tender for the six-in-one vaccine last January.

Glaxo beat Sanofi to come...

Subscribe from just 1€

Exclusive offers

Choose the subscription that is right for you

Monthly Subscription

€1

For the first month

€19.99 Monthly Thereafter

Subscribe today

Cancel anytime

Annual Subscription

€200€149

For the first year

€199.99 annually thereafter

Subscribe today

Cancel anytime

Quarterly Subscription

€55€42

For the first 90 days

€55.00 quarterly Thereafter

Subscribe today

Cancel anytime

These offers are not available for current subscribers. Offers and pricing are subject to change without notice.

Terms & Conditions Apply

Please Subscribe or Log in to continue

Subscribe Login

Related Articles

More from The Business Post